Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Study shows how habits can be controlled based on the activity of the brain region

Each day, humans and animals rely on habits to complete routine tasks such as eating and sleeping. As new habits are formed, this enables us to do things automatically without thinking.

28 Feb 2020

Gene-editing technology may lead to new model for studying Parkinson’s disease

Parkinson's disease researchers have used gene-editing tools to introduce the disorder's most common genetic mutation into marmoset monkey stem cells and to successfully tamp down cellular chemistry that often goes awry in Parkinson's patients.

27 Feb 2020

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest.

27 Feb 2020

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.

27 Feb 2020

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Renishaw, announces that its drug delivery device has played a critical role in the investigation CDNF as a treatment for Parkinson's disease.

From Renishaw plc - Additive Manufacturing for Healthcare Applications 26 Feb 2020

Language may be a promising biomarker for progression of Hungtinton's disease

Huntington's disease is a hereditary neurodegenerative disorder caused by a gene of chromosome 4 that affects a very important area of the brain, the striatum. People are born with the defective gene but symptoms do not appear until the age of 30 or 40.

20 Feb 2020

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

As out-of-pocket costs go up for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribed, according to a study funded by the American Academy of Neurology and published in the February 19, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Feb 2020

Live-cell imaging provides new insights into dynamic structure of mitochondria

As power plants and energy stores, mitochondria are essential components of almost all cells in plants, fungi and animals. Until now, it has been assumed that these functions underlie a static structure of mitochondrial membranes.

18 Feb 2020

Pioneering technique reveals structure of Parkinson's disease protein in action

The top contributor to familial Parkinson's disease is mutations in leucine-rich repeat kinase 2 (LRRK2), whose large and difficult structure has finally been solved, paving the way for targeted therapies.

16 Feb 2020

Lab mice may have differences in small-intestine microbiome as compared to humans

There is a growing consensus that the gut microbiome is involved in many aspects of physical and mental health, including the onset of Parkinson's disease, multiple sclerosis, and even some behaviors.

14 Feb 2020

New study may lead to better treatments for Parkinson's disease

Parkinson's disease is a long-term (chronic) neurological condition that affects around 12,000 people in Ireland and between 7 and 10 million people worldwide. The disease affects the way the brain co-ordinates body movements like walking and talking, but cognitive abilities are also affected.

13 Feb 2020

Light-activated protein restores mitochondrion function in fruit fly model of Parkinson’s disease

A light-sensitive protein can restore mitochondria function in fruit flies bearing a gene mutation associated with Parkinson’s disease and relieve its symptoms, report researchers at Juntendo University in the journal Communications Biology.

13 Feb 2020

AAN issues new guideline for sleep problems in children and teens with autism

It is not uncommon for children and teens with autism spectrum disorder to struggle with sleep. Trouble falling asleep and staying asleep or refusing to go to bed are just some of the sleep problems they can experience.

12 Feb 2020

Researchers identify control of a mitochondrial protective mechanism

Mitochondria are known as the "powerhouses" of cells. However, under critical pathophysiological conditions, they can use cellular energy for self-preservation.

12 Feb 2020

Greater motor reserve in long-distance skiers may help postpone onset of Parkinson's disease

To better understand the relationship between physical activity and Parkinson's Disease (PD) investigators in Sweden analyzed medical records of nearly 200,000 long-distance skiers who took part in the Vasaloppet cross-country ski race.

11 Feb 2020

Blood test for inflammatory and cell senescence biomarkers may help predict cognitive decline

In order to provide the best medical care for newly diagnosed Parkinson's disease (PD) patients, a method of predicting their cognitive and motor progression, beyond using purely clinical parameters, would have major implications for their management.

11 Feb 2020

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Study shows how habits can be controlled based on the activity of the brain region

Gene-editing technology may lead to new model for studying Parkinson’s disease

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Language may be a promising biomarker for progression of Hungtinton's disease

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Live-cell imaging provides new insights into dynamic structure of mitochondria

Pioneering technique reveals structure of Parkinson's disease protein in action

Lab mice may have differences in small-intestine microbiome as compared to humans

New study may lead to better treatments for Parkinson's disease

Light-activated protein restores mitochondrion function in fruit fly model of Parkinson’s disease

AAN issues new guideline for sleep problems in children and teens with autism

Researchers identify control of a mitochondrial protective mechanism

Greater motor reserve in long-distance skiers may help postpone onset of Parkinson's disease

Blood test for inflammatory and cell senescence biomarkers may help predict cognitive decline

Small eye movements play large role in humans' visual acuity

New technology distinguishes between two progressive neurodegenerative diseases

Scientists identify gene as potential therapeutic target for dementia in people with Parkinson's

Exercise found to improve video game performance

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in